ÂÜÀòÂÒÂ×

Gabrielle Heilek is an accomplished professional in the field of oncology and molecular diagnostics, currently serving as Vice President of Research and Development for Oncology at Natera, where responsibilities include overseeing Signatera RUO and oncology innovation. Previous roles include Vice President of Research and Development for Organ Health and Women's Health at Natera, and Senior Director and Head of Clinical Science at Roche Sequencing Solutions, where a team executed registrational studies for medical products. Gabrielle's extensive experience also encompasses leadership positions at Roche Molecular Systems, Artemis Health Inc., and Monogram Biosciences, focusing on projects related to HIV diagnostics, organ health biomarkers, and the development of cutting-edge diagnostic assays. Academic qualifications include a Ph.D. in Molecular, Cellular, and Developmental Biology from the University of California, Santa Cruz, and Master's degrees in Computer Science from the University of Northern British Columbia.